Therapeutic potentials of sarpogrelate in cardiovascular disease.
D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D058830:Serotonin 5-HT2 Receptor Antagonists; D013386:Succinates / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D058830:Serotonin 5-HT2 Receptor Antagonists; D013386:Succinates; C064294:sarpogrelate